Chargement en cours...
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
Blocking IL-1 in patients with knee osteoarthritis is an attractive strategy. Cohen and colleagues report a randomised, placebo-controlled, multiple-dose trial using a monoclonal antibody blocking IL-1 type 1 receptor. They failed to show any positive results in terms of evolution of pain for up to...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3239369/ https://ncbi.nlm.nih.gov/pubmed/21888686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3436 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|